PHIO PHARMACEUTICALS CORP. - COMMON STOCK
0.7869
17-May-24 14:28:52
15 minutes delayed
Stocks
+0.0545
+7.44%
Today's range
0.7504 - 0.8401
ISIN
N/A
Source
NASDAQ
-
Phio Pharmaceuticals Secures New Investor
17 May 2024 08:00:56 By Nasdaq GlobeNewswire
-
Phio Pharmaceuticals Presents This Week at the Society for Investigative Dermatology (SID)
16 May 2024 07:00:00 By Nasdaq GlobeNewswire
-
15 May 2024 12:00:00 By Nasdaq GlobeNewswire
-
Phio Pharmaceuticals Reports Q1 2024 Results and Provides Business Update
09 May 2024 16:25:39 By Nasdaq GlobeNewswire
-
30 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
22 Apr 2024 12:10:09 By Nasdaq GlobeNewswire
-
16 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
11 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
National Spotlight Features Phio’s Innovative RNAi Technology Platform
03 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
02 Apr 2024 06:30:00 By Nasdaq GlobeNewswire
-
21 Mar 2024 06:30:00 By Nasdaq GlobeNewswire
-
13 Mar 2024 13:00:25 By Nasdaq GlobeNewswire
-
06 Mar 2024 09:30:59 By Nasdaq GlobeNewswire
-
31 Jan 2024 07:00:00 By Nasdaq GlobeNewswire
-
Phio Pharmaceuticals Announces Exercise of Warrants for $2.8 Million Gross Proceeds
07 Dec 2023 07:00:00 By Nasdaq GlobeNewswire
-
Phio Pharmaceuticals Reports Third Quarter 2023 Financial Results and Provides Business Update
09 Nov 2023 15:30:20 By Nasdaq GlobeNewswire
-
09 Nov 2023 06:30:00 By Nasdaq GlobeNewswire
-
03 Nov 2023 11:00:00 By Nasdaq GlobeNewswire
-
12 Oct 2023 10:00:00 By Nasdaq GlobeNewswire
-
Phio Pharmaceuticals Presents New Data for Targeting of BRD4 with its INTASYL™ Compound PH-894
11 Oct 2023 06:30:19 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >